Thrombophilic Risk Factors with Valproic Acid

J Gordon Millichap

doi:10.15844/pedneurbriefs-23-2-11

Thrombophilic Risk Factors with Valproic Acid

Pediatric Neurology Briefs

Volume 23 (2009): Issue 2

By: J Gordon Millichap

Open Access

|Feb 2009

Abstract

Thrombophilic risk factors were investigated in 21 children (age range, 1-13 years) with epilepsy and recently treated with valproic acid monotherapy, in a study at Ankara University Medicine Faculty, Turkey.

References

Unal O Deda G Teber S Ertem M Akar N Thrombophilic risk factors in epileptic children treated with valproic acid Pediatr Neurol 2009 Feb 40 2 102 6 10.1016/j.pediatrneurol.2008.10.005 19135623
Open DOI Search in Google Scholar Back to article
Gruppo R Degrauw A Fogelson H Glauser T Balasa V Gartside P Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke J Pediatr 2000 Nov 137 5 714 8 10.1067/mpd.2000.108565 11060540
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-23-2-11 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 16 - 16

Published on: Feb 1, 2009

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Valproic Acid Monotherapy,

Homocysteine,

Fibrinogen Levels

© 2009 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 23 (2009): Issue 2